Invizius

Invizius is a biotech company developing breakthrough treatments for dialysis patients. Its H-Guard product addresses inflammatory responses during dialysis, potentially preventing life-threatening complications. A 'First in Human' study demonstrated safety and tolerability, paving the way for further clinical trials.


Buy Funded Startups lists

Funding Round:

Funding Amount: £950K

Date: 24-Sep-2024

Investors: Mercia Ventures, Calculus Capital, Syensqo, University of Edinburgh's Old College Capital, Scottish Enterprise

Markets: Biotech, Healthtech, Pharmaceutical Manufacturing, Therapeutic Devices, Other Devices and Supplies

HQ: Motherwell, North Lanarkshire, Scotland, United Kingdom

Founded: 2018

Website: https://www.invizius.com/

LinkedIn: https://www.linkedin.com/company/invizius-limited

Twitter: https://twitter.com/inviziusmed

Instagram:

Facebook:

Crunchbase: https://www.crunchbase.com/organization/invizius?utm_source=linkedin&utm_medium=referral&utm_campaign=linkedin_companies&utm_content=profile_cta_anon&trk=funding_crunchbase

Pitchbook: https://pitchbook.com/profiles/company/228270-79


Leave a Comment